MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
22.35%
Quick Ratio
18.61%
Cash Ratio
1.19%
Debt to Asset Ratio
13.90%
Unit: Thousand (K) dollars
Assets Breakdown
    • Other intangible assets, net
    • Current portion of notes receiva...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-controlling interest in subs...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Accounts receivable
0 5 15 NaN
Cash and cash equivalents
20 3 12 624
Inventory
63 63 485 486
Current portion of notes receivable
199 198 199 200
Prepaid expenses and other current assets
95 142 206 171
Total current assets
377 411 917 1,481
Property, plant and equipment, net
NaN NaN 13 14
Other intangible assets, net
16,709 16,994 17,278 17,565
Notes receivable
NaN NaN NaN 0
Total assets
17,086 17,405 18,208 19,060
Note payable, related party
NaN NaN 22,881 22,352
Accounts payable
374 347 576 554
Accrued expenses
210 194 336 266
Due to related party
1,103 621 NaN NaN
Total current liabilities
1,687 1,162 23,793 23,172
Deferred tax liability, net
688 688 3,268 3,268
Total liabilities
2,375 1,850 27,061 26,440
Preferred stock, 0.001 par value 100,000,000 shares authorized, 60,496,041 shares issued and outstanding (60,496,041 on december 31, 2024) liquidation value 0.001 per share, 60,496,041 aggregate. 60,496,041 on december 31, 2024)
NaN NaN 60 60
Common stock, 0.001 par value 4,000,000,000 shares authorized, 107,821,231 shares issued and outstanding on march 31, 2026 (104,621,231 on december 31, 2025)
108 105 12 12
Additional paid-in capital
63,150 62,011 42,871 42,870
Accumulated deficit
-51,794 -49,507 -54,752 -53,283
Total stockholders equity of the company
11,464 12,609 -11,809 -10,341
Non-controlling interest in subsidiaries
3,247 2,946 2,956 2,961
Total stockholders equity
14,711 15,555 -8,853 -7,380
Total liabilities and stockholders equity
17,086 17,405 18,208 19,060
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Current portion of notesreceivable$199K Prepaid expenses andother current assets$95K Inventory$63K Cash and cashequivalents$20K Other intangibleassets, net$16,709K Total current assets$377K Total assets$17,086K Total liabilities andstockholders equity$17,086K Total stockholdersequity$14,711K Total liabilities$2,375K Total stockholdersequity of the company$11,464K Non-controlling interest insubsidiaries$3,247K Total currentliabilities$1,687K Deferred tax liability,net$688K Accumulated deficit-$51,794K Additional paid-in capital$63,150K Due to related party$1,103K Accounts payable$374K Accrued expenses$210K Common stock, 0.001 parvalue 4,000,000,000...$108K

IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC. (IBO)